The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Increased Pituitary Volume in Antipsychotic-Free and Antipsychotic-Treated Patients of the Æsop First-Onset Psychosis Study
Abstract
Subjects at their first psychotic episode show an enlarged volume of the pituitary gland, but whether this is due to hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, or to stimulation of the prolactin-secreting cells by antipsychotic treatment, is unclear. We measured pituitary volume, using 1.5-mm, coronal, 1.5 T, high-resolution MRI images, in 78 patients at the first psychotic episode and 78 age- and gender-matched healthy controls. In all, 18 patients were antipsychotic-free (12 of these were antipsychotic-naïve), 26 were receiving atypical antipsychotics, and 33 were receiving typical antipsychotics. As hypothesized, patients had a larger pituitary volume than controls (+22%, p< 0.001). When divided by antipsychotic treatment, and compared to controls, the pituitary volume was 15% larger in antipsychotic-free patients (p=0.028), 17% larger in patients receiving atypicals (p=0.01), and 30% larger in patients receiving typicals (p<0.001). Patients receiving typicals not only had the largest pituitary volume compared to controls but also showed a trend for a larger pituitary volume compared to the other patients grouped together (+11%, p=0.08). When divided by diagnosis, and compared to controls, the pituitary volume was 24% larger in patients with schizophrenia/schizophreniform disorder (n=40, p<0.001), 19% larger in depressed patients (n=13, p=0.022), 16% larger in bipolar patients (n=16, p=0.037), and 12% larger in those with other psychoses (n=9, p=0.2). In conclusion, the first-episode of a psychotic disorder is associated with a larger pituitary independently of the presence of antipsychotic treatment, and this could be due to activation of the HPA axis. Typical antipsychotics exert an additional enlarging effect on pituitary volume, likely to be related to activation of prolactin-secreting cells. This activation of the hormonal stress response could participate to the important metabolic abnormalities observed in patients with psychosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pituitary volume changes have been reported in MDD with both increased (46, 47), reduced or not change in volume reported (48–50).”
From Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis (2022) · cites this paper as [47]
In the citing paper
“The normal, dynamic development of the pituitary appears to be altered, with increased size prior to psychosis onset, and reduced size in chronic psychotic conditions, compared with normal groups [50-53] , although not all studies have reported this [54] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [52]
Citations
Cites
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
Measurement and classification of psychiatric symptoms
Goldberg, D. P. (1975) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(75)90076-8 · Cited by 2,194
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Self-citationD'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 924
Self-citationQuantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P. B., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U. M., Borenstein, J. E., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 758
Magnetic Resonance Imaging of the Brain and Spine
HEALTH AND PUBLIC POLICY COMMITTEE* (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-474 · Cited by 725
Emotional Reactivity to Daily Life Stress in Psychosis
Myin-Germeys, I., van Os, J., Schwartz, J. E., Stone, A. A., & Delespaul, P. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1137 · Cited by 653
Evidence of a Dose-Response Relationship Between Urbanicity During Upbringing and Schizophrenia Risk
Pedersen, C. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1039 · Cited by 647
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
Magnetic Resonance Imaging of the Brain and Spine
Nayak, S. M. (1996) · Radiology · doi:10.1148/radiology.200.2.406 · Cited by 539
Boydell, J. E., van Os, J., McKenzie, K. J., Allardyce, J., Goel, R., McCreadie, R. G., & Murray, R. M. (2001) · BMJ · doi:10.1136/bmj.323.7325.1336 · Cited by 486
Self-citationKinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
Bánki, C. M., Bissette, G., Arató, M., O'Connor, L., & Nemeroff, C. B. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.873 · Cited by 336
Modern imaging of the pituitary.
Elster, A. D. (1993) · Radiology · doi:10.1148/radiology.187.1.8451394 · Cited by 324
Ectopic Secretion of Corticotropin-Releasing Factor as a Cause of Cushing’s Syndrome
Carey, R. M., Varma, S. K., Drake, C. R., Thorner, M. O., Kovács, K., Rivier, J., & Vale, W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407053110103 · Cited by 278
Life Events and Psychosis: Initial Results from the Camberwell Collaborative Psychosis Study
Bebbington, P., Wilkins, S., Jones, P., Foerster, A., Murray, R., Toone, B., & Lewis, S. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.72 · Cited by 273
Self-citationDazzan, P., Morgan, K. D., Orr, K., Hutchinson, G. A., Chitnis, X. A., John Suckling, A., Fearon, P., McGuire, P. K., Mallett, R., Jones, P. B., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300603 · Cited by 260
Self-citationDepression, Stress and the Adrenal axis
(2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.01058.x · Cited by 242
Self-citationKRISHNAN, K. R. R., DORAISWAMY, P. M., LURIE, S. N., FIGIEL, G. S., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., & NEMEROFF, C. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-256 · Cited by 232
The structural brain correlates of neurological soft signs in AeSOP first-episode psychoses study
Dazzan, P. (2003) · Brain · doi:10.1093/brain/awh015 · Cited by 232
Self-citationRyan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225
Neighbourhood variation in incidence of schizophrenia
van Os, J., Driessen, G., Günther, N., & Delespaul, P. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.176.3.243 · Cited by 207
Saiardi, A., Bozzi, Y., Baik, J., & Borrelli, E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80352-9 · Cited by 202
Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia
Walder, D. J., Walker, E. F., & Lewine, R. J. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01052-0 · Cited by 192
Ryan, M. C. M., Flanagan, S., Kinsella, U., Keeling, F., & Thakore, J. H. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.08.044 · Cited by 190
Pariante, C. M., Vassilopoulou, K., Velakoulis, D., Phillips, L., Soulsby, B., Wood, S. J., Brewer, W., Smith, D., Dazzan, P., Yung, A. R., et al. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.1.5 · Cited by 180
Self-citationChronic Administration of Corticotropin-Releasing Factor Increases Pituitary Corticotroph Number*
Gertz, B. J., Contreras, L. N., McComb, D. J., Kovács, K., Tyrrell, J., & Dallman, M. F. (1987) · Endocrinology · doi:10.1210/endo-120-1-381 · Cited by 174
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia
Rao, M. L., Gross, G., Strebel, B., Halaris, A., Huber, G., Bräunig, P., & Marler, M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91147-9 · Cited by 154
Lammers, C.-H., Garcı́a-Borreguero, D., Schmider, J., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. E. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00065-8 · Cited by 153
In VivoAssessment of Pituitary Gland Volume with Magnetic Resonance Imaging: The Effect of Age*
Lurie, S. N., Doraiswamy, P. M., Husain, M. M., Boyko, O. B., Ellinwood, E. H., Figiel, G. S., & Krishnan, K. R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-505 · Cited by 147
Axelson, D., Doraiswamy, P. M., Boyko, O. B., Escalona, P. R., McDonald, W. M., Ritchie, J., Patterson, L. J., Ellinwood, E. H., Nemeroff, C. B., & Krishnan, K. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90070-j · Cited by 147
Kunzel, H. E., Binder, E. B., Nickel, T., Ising, M., Fuchs, B., Majer, M., Pfennig, A., Ernst, G., Kern, N., Schmid, D. A., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300280 · Cited by 143
Decreased pituitary volume in patients with bipolar disorder
Sassi, R. B., Nicoletti, M., Brambilla, P., Harenski, K. A., Mallinger, A. G., Frank, E., Kupfer, D. J., Keshavan, M. S., & Soares, J. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01086-1 · Cited by 135
Miller, D. D., Andreasen, N. C., OʼLeary, D. S., Watkins, G. L., Ponto, L. L. B., & Hichwa, R. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01001-5 · Cited by 127
The 24-Hour Profiles of Cortisol, Prolactin, and Growth Hormone Secretion in Mania
Linkowski, P. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950080028004 · Cited by 116
Hormonal aspects of schizophrenias: an overview
Halbreich, U. M., & Kahn, L. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00124-5 · Cited by 111
Bergemann, N., Mundt, C., Parzer, P., Jannakos, I., Nagl, I., Salbach, B., Klinga, K., Runnebaum, B., & Resch, F. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.06.013 · Cited by 109
Incidence of schizophrenia in south-east London between 1965 and 1997
Boydell, J., Van Os, J., Lambri, M., Castle, D., Allardyce, J., McCreadie, R. G., & Murray, R. M. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.1.45 · Cited by 104
Self-citationEffect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography
Miller, D. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00042-0 · Cited by 103
Estradiol levels in psychotic disorders
Huber, T. J., Rollnik, J. D., Wilhelms, J., Mühlen, A. V. Z., Emrich, H. M., & Schneider, U. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00034-2 · Cited by 103
Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women
Mück‐Šeler, D., Pivac, N., Mustapić, M., Crnčević, Ž., Jakovljević, M., & Šagud, M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.001 · Cited by 103
Stress and the progression of the developmental hypothesis of schizophrenia
Cotter, D., & Pariante, C. M. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.5.363 · Cited by 100
Self-citationWestlund, K. N., Aguilera, G., & Childs, G. V. (1985) · Endocrinology · doi:10.1210/endo-116-1-439 · Cited by 99
Psychoendocrinology of Ego Disintegration
Sachar, E. J., Kanter, S. S., BUIE, D., Engle, R. L., & Mehlman, R. D. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.8.1067 · Cited by 98
MRI study of the pituitary gland in adolescent depression
MacMaster, F. P., & Kusumakar, V. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.001 · Cited by 85
A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis
Pariante, C. M., Papadopoulos, A. S., Poon, L., Checkley, S. A., English, J., Kerwin, R. W., & Lightman, S. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01314-2 · Cited by 74
Self-citationMiller, D. D., Rezai, K., Alliger, R. J., & Andreasen, N. C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00110-2 · Cited by 74
Stress and the genesis of diabetes mellitus in schizophrenia
Dinan, T. G. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.47.s72 · Cited by 58
The dexamethasone suppression test in newly hospitalized schizophrenic patients
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.1.127 · Cited by 56
Pérez, R., Machiavelli, G. A., Romano, M. I., & Burdman, J. A. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080399 · Cited by 53
Segal, M., Avital, A., Rojas, M., Hausvater, N., Sandbank, S., Liba, D., Moguillansky, L., Tal, I., & Weizman, A. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.01.010 · Cited by 40
Chen, H. H., Nicoletti, M., Sanches, M., Hatch, J. P., Sassi, R. B., Axelson, D., Brambilla, P., Keshavan, M. S., Ryan, N. D., Birmaher, B. B., et al. (2004) · Depression and Anxiety · doi:10.1002/da.20044 · Cited by 39
Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up
Coryell, W. H., & Tsuang, D. W. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1033 · Cited by 39
Campeau, S. (2002) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00245-x · Cited by 36
Asa, S. L., Kovács, K., Hammer, G. D., Liu, B., Roos, B. A., & Low, M. J. (1992) · Endocrinology · doi:10.1210/endo.131.2.1322279 · Cited by 35
Case report: Pituitary enlargement associated with Addison's disease
Mineura, K., Tsuneo, G. O. T. O., Yoneya, M., Kowada, M., Tamakawa, Y., & Kagaya, H. (1987) · Clinical Radiology · doi:10.1016/s0009-9260(87)80258-1 · Cited by 25
Lower prolactin bioactivity in unmedicated schizophrenic patients
Warner, M. D., Walker, A. M., D’Souza, D. C., Lee, D., Nasseri, D., & Peabody, C. A. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00256-6 · Cited by 18
Corticotroph cell hyperplasia in a patient with addison disease: Case report
Kubota, T., Hayashi, M., Kabuto, M., Shirasaki, N., Aradachi, H., Miyanaga, K., & Miyabo, S. (1992) · Surgical Neurology · doi:10.1016/0090-3019(92)90132-7 · Cited by 17
Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., Brewer, W. J., Smith, D. J., Dazzan, P., Berger, G. E., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.018 · Cited by 8
Self-citationHerz, M. I., Molnar, G., & Fava, G. A. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.8.1000 · Cited by 3
Research works printed but not linked: 1
- Wing J, Sturt E (1978). The PSE-ID-CATEGO System: Supplementary Manual. Medical Research Council: London.
Cited by
Sorted by citations
Stress-reactivity in psychosis: Evidence for an affective pathway to psychosis
Myin-Germeys, I., & van Os, J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.09.005 · Cited by 719
Morgan, C., & Fisher, H. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl053 · Cited by 568
Self-citationGlucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Self-citationMeta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder
Kempton, M. J., Geddes, J. R., Ettinger, U., Williams, S., & Grasby, P. M. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1017 · Cited by 547
Arnone, D., McIntosh, A. M., Ebmeier, K. P., Munafò, M. R., & Anderson, I. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.003 · Cited by 495
Metadata
- Authors
- Pariante, C. M., Dazzan, P., Danese, A., Morgan, K. D., Brudaglio, F., Morgan, C., Fearon, P., Orr, K., Hutchinson, G., Pantelis, C., Velakoulis, D., Jones, P. B., Leff, J., & Murray, R. M.
- Affiliations
- King's College London (GB)
- Sir Charles Gairdner Hospital (AU)
- University of the West Indies (TT)
- The Royal Melbourne Hospital (AU)
- University of Cambridge (GB)
- Corresponding author
- Pariante, Carmine M
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2005-06-01
- Volume
- 30
- Issue
- 10
- Pages
- 1923-1931
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978625524
- Cited by
- 152
- References
- 66
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2020: 2 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 14 · 2014: 10 · 2013: 13 · 2012: 4
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- pituitary volume, first-episode psychosis, antipsychotic drugs, typical antipsychotics, atypical antipsychotics, hypothalamic-pituitary-adrenal axis, HPA axis hyperactivity, schizophrenia, bipolar disorder, depression
- MeSH terms
- Adolescent, Adult, Aged, Analysis of Variance, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Pituitary Gland, Psychotic Disorders, Time Factors, Antipsychotic Agents, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review